Skip to content
Nutex Health
  • Home
  • Leadership
  • Locations
  • Careers
  • Investors
    • Media
    • Press Releases
    • SEC Filings
    • Governance
      • Board of Directors
      • Board Committee
      • Governance Documents
    • Investor Relations Contacts
    • Investor Materials
    • Analyst Coverage
      • Benchmark – Bill Sutherland
      • Maxim Group – Anthony Vendetti
      • Freedom Capital Markets – Gene Mannheimer
  • Billing
    • Pay A Bill
  • Contact
☏ 713-660-0557 ✉ info@nutexhealth.com
FacebookTwitterLinkedin
Nutex Health
  • Home
  • Leadership
  • Locations
  • Careers
  • Investors
    • Media
    • Press Releases
    • SEC Filings
    • Governance
      • Board of Directors
      • Board Committee
      • Governance Documents
    • Investor Relations Contacts
    • Investor Materials
    • Analyst Coverage
      • Benchmark – Bill Sutherland
      • Maxim Group – Anthony Vendetti
      • Freedom Capital Markets – Gene Mannheimer
  • Billing
    • Pay A Bill
  • Contact

SEC Filings

Latest Filings

April 26, 2022

 

8-K

April 26, 2022

 

Exhibit 10

View PDF
View PDF
View HTML
View HTML

April 13, 2022

 

Schedule 13-D

Form D

View 13-D
View Form D

April 4, 2022

 

8-K

View PDF
View HTML
View XBRL
Documents Expand

EX-3.1
EX-3.2
EX-10.1
EX-10.2
EX-10.3

XBRL (HTML)

April 1, 2022

 

10-K

View PDF
View HTML

SEC Filings

Annual Reports
Quartely Reports
Section 16 Filings

1776 Yorktown St, Suite 700
Houston, Texas 77056

phone: 713-660-0557
e-mail: info@nutexhealth.com

About

  • Our Leadership
  • Locations
  • Contact Us
  • Whistleblower Policy
© 2025 Nutex Health